Fruquintinib Plus TAS-102 With or Without SBRT as Third- Or Later-Line Therapy for Metastatic Colorectal Cancer: Preliminary Results From a Prospective Phase II Trial
呋喹替尼联合TAS-102（无论是否联合SBRT）作为转移性结直肠癌的三线或后续治疗：一项前瞻性II期试验的初步结果
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71884
Wang, Yi; Xu, Jianfen; Liang, Linchun; Chen, Yunjie; Fei, Leizheng; Hu, Jing; Li, Jianjiong; Lu, Yi; Ren, Feng; Chen, Ke; Shen, Yanping; Tao, Qingsong; Fang, Zhi; Liu, Kaitai; Ye, Hua; Zhang, Jing; Xu, Yunbao; Mao, Haoxun; Zhang, Chen; Rao, Chuangzhou
